Erste Asset Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,400	Closed	-$660K	–	756
2025 Q3	$660K	Buy	41,400 +20,700	+100%	+$306K	0.01%	448
2025 Q2	$279K	Hold	20,700	–	–	﹤0.01%	717
2025 Q1	$223K	Hold	20,700	–	–	﹤0.01%	469
2024 Q4	$340K	Hold	20,700	–	–	﹤0.01%	466
2024 Q3	$1.17M	Hold	20,700	–	–	0.01%	376
2024 Q2	$933K	Hold	20,700	–	–	0.01%	378
2024 Q1	$1.34M	Buy	20,700 +15,000	+263%	+$889K	0.02%	343
2023 Q4	$234K	Hold	5,700	–	–	﹤0.01%	479
2023 Q3	$186K	Hold	5,700	–	–	﹤0.01%	483
2023 Q2	$227K	Hold	5,700	–	–	﹤0.01%	483
2023 Q1	$240K	Hold	5,700	–	–	﹤0.01%	479
2022 Q4	$274K	Hold	5,700	–	–	0.01%	465
2022 Q3	$207K	Hold	5,700	–	–	﹤0.01%	495
2022 Q2	$155K	Hold	5,700	–	–	﹤0.01%	528
2022 Q1	$306K	Hold	5,700	–	–	0.01%	478
2021 Q4	$318K	Hold	5,700	–	–	0.01%	470
2021 Q3	$234K	Hold	5,700	–	–	﹤0.01%	468
2021 Q2	$242K	Hold	5,700	–	–	﹤0.01%	464
2021 Q1	$328K	Hold	5,700	–	–	0.01%	421
2020 Q4	$425K	Buy	+5,700	New	+$359K	0.01%	402